Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-019229
Filing Date
2017-05-10
Accepted
2017-05-10 09:59:20
Documents
2
Period of Report
2017-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6478
2 poa_matthewkapusta.htm EX-24 8222
  Complete submission text file 0001140361-17-019229.txt   16014
Mailing Address 7358 MCVAY ROAD GERMANTOWN TN 38138
Business Address
Kapusta Matthew C (Reporting) CIK: 0001536290 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 17828812

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations